Clinical Trial Update: A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects [Phase 4]

View source ↗

Summary

Phase 4 study evaluating VI-0521 on ambulatory blood pressure in overweight or obese adults has completed, with results posted on 2024-06-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• VI-0521

Snippet

Sponsor: VIVUS LLC | Conditions: Blood Pressure | Phase 4 | Status: COMPLETED | Results posted: 2024-06-18